Mycophenolic Acid (MPA) 霉酚酸(麦可酚酸)


描述

Mycophenolic Acid (MPA) 霉酚酸(麦可酚酸)

产品标签

Mycophenolic Acid (MPA) 霉酚酸;Immunosuppressive Drug 免疫抑制剂;Inosine monophosphatase dehydrogenase次黄嘌呤单核苷酸脱氢酶;IMPDH Inhibitor; Mycophenolate mofetil 吗替麦考酚酯;CAS NO:24280-93-1;

产品信息

产品名称 产品编号 CAS NO.         规格            价格(元) 
Mycophenolic Acid (MPA) 霉酚酸(麦可酚酸)    MZ9231-0100MG     24280-93-1 100mg 298
Mycophenolic Acid (MPA) 霉酚酸(麦可酚酸) MZ9231-1000MG 24280-93-1 1g 1178

产品描述

霉酚酸(Mycophenolic Acid,MPA),又名麦可酚酸,是一种免疫抑制剂,用来预防器官移植后的排斥反应。MPA的功能在其是一种有效且可逆的次黄嘌呤单核苷酸脱氢酶(IMPDH)抑制剂,淋巴细胞中能阻断GTP的从头合成并引起RNA和DNA合成的减少,从而防止淋巴细胞增殖和活化,并抑制抗体生成。MPA还具有抗真菌、抗细菌、抗病毒和抗肿瘤效应。

产品特性

1)CAS NO:24280-93-1

2)化学名:6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid

3)同义名:MPA;NSC 129185;

4)分子式:C17H20O6

5)分子量:320.34

6)纯度:≥98%

7)外观:白色或类白色粉末

8)溶解性:溶于乙醇、甲醇、DMSO(30mg/ml)、不溶于水

9)化学结构图:

保存与运输方法

保存:2-8ºC干燥保存,或置于-20ºC长期干燥保存,至少2年有效。

运输:室温运输。

注意事项

1)本霉酚酸(MPA)不是临床药物,只能用于科研用途,不能用于诊断或临床用途。

2)为了您的安全和健康,请穿实验服并戴一次性手套操作。

使用方法【源自文献,仅作参考】

文献1,Azzarone A et al. Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1. Transplant Proc. 1992 Dec;24(6):2868-71. PMID: 1465977

体外研究:

细胞类型(Cell type):Hepatocytes (from rat liver) in Primary Culture

药物配制(Preparation):MPA was dissolved in DMSO

实验方法(Assay):MPA was dissolved in DMSO and added in the appropriate concentrations (0.6, 1.2, 2.4, 5, 10 μg/ml). The amount of DMSO added to the medium was never more than 2 μL/mL, which does not affect hepatocyte proliferation. The in vitro DNA synthesis was detected by [3H] Thymidine Incorporation.

体内研究:

动物模型(Animal Model):70% partial hepatectomy rat model

药物配制(Preparation):MPA was dissolved in 0.5% carbossil-methil-cellulose (CMC), 0.4% Tween, and 0.9% alcohol in saline.

注射剂量(Dosages):Rats were assigned to groups and treated for 4 days as controls or with MPA (15mg/kg).On the 4th day, between 0900 and 1030 hours, the rats received a standard 70% hepatectomy under light ether anesthesia. Food and drink were allowed immediately. Twenty-four hours after the hepatectomies, 185 × 10−4Bq [3H] thymidine was administered to all rats by intraperitoneal injection.

给药途径(Administration):Oral (p.o.)

文献2,Sugiyama K et al. Peripheral Lymphocyte Response to Mycophenolic Acid In Vitro and Incidence of Cytomegalovirus Infection in Renal Transplantation. Cell Med. 2013 Oct 23;6(1-2):47-55. PMID: 26858880

体外研究:

细胞类型(Cell type):PBMCs

药物配制(Preparation):MPA was dissolved in Ethanol

实验方法(Assay):PBMCs was placed into each well of a 96-well flat-bottomed microplate.Saline containing concanavalin A was added to each well to a final mitogen concentration of 5.0 µg/ml. Subsequently, an ethanol solution containing MPA was added to give a final drug concentration of 0.001, 0.01, 0.1, 1, 10, 100, 1,000, or 10,000 ng/ml. The same volume of each vehicle solution was added to the control wells (no concanavalin A or MPA treatment). After 4 days of culture, MTT assay was done.

相关产品

货号                          名称                      规格         
MZ9231-0100MG Mycophenolic Acid (MPA) 霉酚酸(麦可酚酸)    100mg
MZ9232-0100MG Mycophenolate mofetil 吗替麦考酚酯 100mg